U.S. Federal Register Tool

Ending Birth Tourism

Continuing To Protect the Meaning and Value of American Citizenship

National Purple Heart Day, 2026

Adjusting Imports of Polysilicon and Its Derivatives Into the United States

Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V

The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), and daridorexant ([(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1- yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone) from schedule IV to schedule V of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule V controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle suvorexant, lemborexant, and daridorexant.

NRC Modernization: Rulemaking Procedure, Federal Advisory Committee Act Alignment, Access, and Security

The U.S. Nuclear Regulatory Commission (NRC) is amending its regulations by streamlining procedural provisions related to information withholding and post-promulgation comment periods; aligning the NRC's regulations with Committee Management Secretariat (CMS) Federal Advisory Committee Act (FACA) standards; and updating national security eligibility criteria. The goal is to modernize and clarify the NRC's regulatory framework to ensure consistency with government-wide standards and improve administrative efficiency. The scope includes updates to outdated provisions and revisions to ensure compliance with current federal policies. This action is being taken in response to Executive Order 14300, "Ordering the Reform of the Nuclear Regulatory Commission."

NRC Modernization: Rulemaking Procedure, Federal Advisory Committee Act Alignment, Access, and Security

The U.S. Nuclear Regulatory Commission (NRC) is proposing to amend its regulations by streamlining procedural provisions related to information withholding and post-promulgation comment periods; aligning the NRC's regulations with Committee Management Secretariat (CMS) Federal Advisory Committee Act (FACA) standards; and updating national security eligibility criteria. The goal is to modernize and clarify the NRC's regulatory framework to ensure consistency with government-wide standards and improve administrative efficiency. The scope includes updates to outdated provisions and revisions to ensure compliance with current federal policies. This action is being undertaken in response to Executive Order 14300, "Ordering the Reform of the Nuclear Regulatory Commission."

Reforms to 13 CFR 124.103 To Remove SBA's 8(a) Program's Rebuttable Presumption of Social Disadvantage for Individually Owned Firms Only. Reforms Do Not Impact Entity-Owned Firms

The U.S. Small Business Administration ("SBA" or "Agency") amends its regulations to align the Section 8(a) Business Development Program (8(a) BD program) with constitutional requirements and the law. The rule applies only to the 8(a) BD eligibility of small businesses owned and controlled by individuals. It does not in any way amend or affect the eligibility of entity-owned small businesses (i.e., those owned by tribes, Alaska Native Corporations, Native Hawaiian Organizations, or Community Development Corporations). Specifically, the rule amends SBA's regulations to remove the rebuttable presumption that individuals belonging to certain designated groups are socially disadvantaged and sets forth revised standards for individuals establishing social disadvantage.

Medicare Program; Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway

This notice with comment period provides information to the public on the process CMS will use to provide accelerated Medicare coverage through the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway for new innovative technologies. The RAPID coverage pathway leverages existing processes to provide expedited national Medicare coverage for eligible technologies. This notice with comment period solicits public comment on the proposed RAPID coverage pathway.

Marine Mammals; Incidental Take During Specified Activities; Proposed Incidental Harassment Authorization for Southwest Alaska Stock of Northern Sea Otters in Unalaska, Alaska

We, the U.S. Fish and Wildlife Service (FWS), in response to a request under the Marine Mammal Protection Act of 1972, as amended, from the City of Unalaska, propose to authorize incidental take by harassment of small numbers of Southwest Alaska stock northern sea otters (Enhydra lutris kenyoni) for a period of up to 1 year from the date of issuance. The applicant has requested this authorization for take by harassment that may result from activities associated with pile driving and marine construction at the Robert Storrs Harbor in Unalaska, Alaska. This proposed authorization, if finalized, would be for incidental take by Level A harassment and Level B harassment of northern sea otters from the Southwest Alaska stock. We invite comments on the proposed incidental harassment authorization and the accompanying draft environmental assessment from the public, Tribes, and local, State, and Federal agencies.